Skip to main content

Advertisement

SpringerLink
Log in

Chronic infections and atherosclerosis/thrombosis

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

An emerging pathophysiologic paradigm implicates chronic inflammation in the initiation, progression, and destabilization of atherosclerotic vascular disease. Various potential contributors to the inflammatory response in the vessel wall include atherogenic lipids, mechanical stress and injury, hypertension and angiotensin II, cigarette smoking, immune response to neoantigens, and chronic infections with viruses and or bacteria (Table I). The potential link between chronic infection and atherosclerosis/thrombosis is under extensive investigation in several laboratories around the world. Although indirect evidence and experimental data tend to support this link, definitive proof is still lacking. If such a link is eventually proven to be causal in nature, it will provide a novel target for preventive and therapeutic strategies (anti-infective drugs, vaccines, etc.) against a common disease that is the leading killer of people in Western nations. Results of ongoing, large-scale clinical trials are eagerly awaited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Ross R: Atherosclerosis is an inflammatory disease. Am Heart J 1999, 138:S419–420.

    Article  PubMed  CAS  Google Scholar 

  2. Shah PK: Plaque disruption and thrombosis: potential role of inflammation and infection. Cardiol Rev 2000, 8:31–39.

    Article  PubMed  CAS  Google Scholar 

  3. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997, 96:4095–4103.

    PubMed  CAS  Google Scholar 

  4. Osler W: Disease of the Arteries. Philadelphia: Lea and Febiger; 1908.

    Google Scholar 

  5. Klotz MM: Fatty streaks in intima of arteries. J Pathol Bacteriol 1912, 16:211–220.

    Article  Google Scholar 

  6. Frothingham C: The relationship between acute infectious diseases and arterial lesions. Arch Intern Med 1911, 8:153–162.

    Google Scholar 

  7. Leary T: Pathology of coronary stenosis. Am Heart J 1935, 10:423–426.

    Google Scholar 

  8. Saikku P, Leinonen M, Mattila K, et al.: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983–986.

    Article  PubMed  CAS  Google Scholar 

  9. Saikku P, Leinonen M, Tenkanen L, et al.: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992, 116:273–278.

    PubMed  CAS  Google Scholar 

  10. Shah PK: Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? Circulation 2001, 103:5–6.

    PubMed  CAS  Google Scholar 

  11. Fabricant CG, Fabricant J, Litrenta MM, Minick CR: Virus-induced atherosclerosis. J Exp Med 1978, 148:335–340.

    Article  PubMed  CAS  Google Scholar 

  12. Minick CR, Fabricant CG, Fabricant J, Litrenta MM: Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol 1979, 96:673–706.

    PubMed  CAS  Google Scholar 

  13. Lemstrom K, Sihvola R, Bruggeman C, et al.: Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation. 1997, 95:2614–2616.

    PubMed  CAS  Google Scholar 

  14. Hsich E, Zhou YF, Paigen B, et al.: Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis 2001, 156:23–28.

    Article  PubMed  CAS  Google Scholar 

  15. Zhou YF, Shou M, Harrell RF, et al.: Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc Res 2000, 45:1019–1025.

    Article  PubMed  CAS  Google Scholar 

  16. Speir E, Yu ZX, Ferrans VJ: Infectious agents in coronary artery disease: viral infection, aspirin, and gene expression in human coronary smooth muscle cells. Rev Port Cardiol 1998, 17(suppl 2):II33–39.

    PubMed  Google Scholar 

  17. Jacob HS, Visser M, Key NS, et al.: Herpes virus infection of endothelium: new insights into atherosclerosis. Trans Am Clin Climatol Assoc 1992, 103:95–104.

    PubMed  CAS  Google Scholar 

  18. Danesh J, Collins R, Peto R: Chronic infections and coronary heart disease: is there a link? Lancet 1997, 350:430–436.

    Article  PubMed  CAS  Google Scholar 

  19. Adler SP, Hur JK, Wang JB, Vetrovec GW: Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J Infect Dis 1998, 177:209–212.

    PubMed  CAS  Google Scholar 

  20. Zhou YF, Leon MB, Waclawiw MA, et al.: Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996, 335:624–630.

    Article  PubMed  CAS  Google Scholar 

  21. Ridker PM, Hennekens CH, Stampfer MJ, Wang F: Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998, 98:2796–2799.

    PubMed  CAS  Google Scholar 

  22. Sorlie PD, Nieto FJ, Adam E, et al.: A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 2000, 160:2027–2032.

    Article  PubMed  CAS  Google Scholar 

  23. Siscovick DS, Schwartz SM, Corey L, et al.: Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation 2000, 102:2335–2340.

    PubMed  CAS  Google Scholar 

  24. Manegold C, Alwazzeh M, Jablonowski H, et al.: Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation 1999, 99:1290–1294.

    PubMed  CAS  Google Scholar 

  25. Neumann FJ, Kastrati A, Miethke T, et al.: Previous cytomegalovirus infection and restenosis after coronary stent placement. Circulation 2001, 104:1135–1139.

    PubMed  CAS  Google Scholar 

  26. Zhu J, Quyyumi AA, Norman JE, et al.: The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000, 182:1583–1587.

    Article  PubMed  CAS  Google Scholar 

  27. Naghavi M, Barlas Z, Siadaty S, et al.: Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000, 102:3039–3045.

    PubMed  CAS  Google Scholar 

  28. Grayston JT: Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992, 15:757–761.

    PubMed  CAS  Google Scholar 

  29. Grayston JT, Kuo CC, Campbell LA, Benditt EP: Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993, 14(suppl K):66–71.

    PubMed  Google Scholar 

  30. Fong IW, Chiu B, Viira E, et al.: Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 1997, 35:48–52.

    PubMed  CAS  Google Scholar 

  31. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P: Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immunol 1997, 65:4832–4835.

    CAS  Google Scholar 

  32. Muhlestein JB, Anderson JL, Hammond EH, et al.: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998, 97:633–636.

    PubMed  CAS  Google Scholar 

  33. Fong IW, Chiu B, Viira E, Jang D, Mahony JB: De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immunol 1999, 67:6048–6055.

    CAS  Google Scholar 

  34. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC: Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 1999, 180:238–241.

    Article  PubMed  CAS  Google Scholar 

  35. Hu H, Pierce GN, Zhong G: The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999, 103:747–753.

    PubMed  CAS  Google Scholar 

  36. Caligiuri G, Rottenberg M, Nicoletti A, Wigzell H, Hansson GK: Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 2001, 103:2834–2838.

    PubMed  CAS  Google Scholar 

  37. Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ: Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis 2001, 183:232–238.

    Article  PubMed  CAS  Google Scholar 

  38. Kol A, Libby P: Molecular mediators of arterial inflammation: a role for microbial products? Am Heart J 1999, 138:S450–452.

    Article  PubMed  CAS  Google Scholar 

  39. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D: Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998, 120:93–99.

    Article  PubMed  CAS  Google Scholar 

  40. Maass M, Gieffers J: Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile. J Infect 1997, 35:171–176.

    Article  PubMed  CAS  Google Scholar 

  41. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999, 30:299–305.

    PubMed  CAS  Google Scholar 

  42. Miyashita N, Toyota E, Sawayama T, et al.: Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Intern Med 1998, 37:913–916.

    PubMed  CAS  Google Scholar 

  43. Thomas M, Wong Y, Thomas D, et al.: Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque. Circulation. 1999, 99:2733–2736.

    PubMed  CAS  Google Scholar 

  44. Cook PJ, Honeybourne D, Lip GY, et al.: Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke 1998, 29:404–410.

    PubMed  CAS  Google Scholar 

  45. Strachan DP, Carrington D, Mendall MA, et al.: Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ 1999, 318:1035–1039.

    PubMed  CAS  Google Scholar 

  46. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH: Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999, 99:1161–1164.

    PubMed  CAS  Google Scholar 

  47. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J: Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999, 131:573–577.

    PubMed  CAS  Google Scholar 

  48. Nieto FJ, Folsom AR, Sorlie PD, et al.: Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999, 150:149–156.

    PubMed  CAS  Google Scholar 

  49. Grayston JT, Campbell LA: The role of Chlamydia pneumoniae in atherosclerosis. Clin Infect Dis 1999, 28:993–994.

    PubMed  CAS  Google Scholar 

  50. Weiss SM, Roblin PM, Gaydos CA, et al.: Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996, 173:957–962.

    PubMed  CAS  Google Scholar 

  51. Campbell LA, O’Brien ER, Cappuccio AL, et al.: Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 1995, 172:585–588.

    PubMed  CAS  Google Scholar 

  52. Paterson DL, Hall J, Rasmussen SJ, Timms P: Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 1998, 30:169–172.

    Article  PubMed  CAS  Google Scholar 

  53. Jackson LA, Campbell LA, Schmidt RA, et al.: Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997, 150:1785–1790.

    PubMed  CAS  Google Scholar 

  54. Jantos CA, Nesseler A, Waas W, et al.: Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clin Infect Dis 1999, 28:988–992.

    PubMed  CAS  Google Scholar 

  55. Ramirez JA: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 1996, 125:979–982.

    PubMed  CAS  Google Scholar 

  56. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH: Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998, 31:827–832.

    Article  PubMed  CAS  Google Scholar 

  57. Meier CR, Derby LE, Jick SS, Vasilakis C, Jick H: Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA 1999, 281:427–431.

    Article  PubMed  CAS  Google Scholar 

  58. Jackson LA, Smith NL, Heckbert SR, et al.: Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. Emerg Infect Dis 1999, 5:281–284.

    Article  PubMed  CAS  Google Scholar 

  59. Gupta S, Leatham EW, Carrington D, et al.: Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 1997, 96:404–407.

    PubMed  CAS  Google Scholar 

  60. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B: Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group. Lancet 1997, 350:404–407.

    Article  PubMed  CAS  Google Scholar 

  61. Gurfinkel E, Bozovich G, Beck E, et al.: Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J 1999, 20:121–127.

    Article  PubMed  CAS  Google Scholar 

  62. Anderson JL, Muhlestein JB, Carlquist J, et al.: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study. Circulation 1999, 99:1540–1547.

    PubMed  CAS  Google Scholar 

  63. Stone AF, Kaski Juan-Carlos MM, Sandy G, John C, Northfield T: Antibiotics against chlamydia pneumoniae and helicobacter pylori reduce further cardiovascular events in patients with acute coronary syndromes. J Am Coll Cardiol 2001, 37 (suppl A):1A-648A.

    Google Scholar 

  64. Neumann F, Kastrati A, Miethke T, et al.: Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR- 3): a randomised, double-blind, placebo-controlled trial. Lancet 2001, 357:2085–2089.

    Article  PubMed  CAS  Google Scholar 

  65. Ossei-Gerning N, Moayyedi P, Smith S, et al.: Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 1997, 35:120–124.

    Article  PubMed  CAS  Google Scholar 

  66. Markus HS, Mendall MA: Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998, 64:104–107.

    Article  PubMed  CAS  Google Scholar 

  67. de Luis DA, Lahera M, Canton R, et al.: Association of Helicobacter pylori infection with cardiovascular and cerebrovascular disease in diabetic patients. Diabetes Care 1998, 21:1129–1132.

    Article  PubMed  Google Scholar 

  68. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY: Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998, 98:845–850.

    PubMed  CAS  Google Scholar 

  69. Khurshid A, Fenske T, Bajwa T, Bourgeois K, Vakil N: A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease. Am J Gastroenterol 1998, 93:717–720.

    Article  PubMed  CAS  Google Scholar 

  70. Blasi F, Denti F, Erba M, et al.: Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996, 34:2766–2769.

    PubMed  CAS  Google Scholar 

  71. Danesh J, Koreth J, Youngman L, et al.: Is Helicobacter pylori a factor in coronary atherosclerosis? J Clin Microbiol 1999, 37:1651.

    PubMed  CAS  Google Scholar 

  72. Kweider M, Lowe GD, Murray GD, Kinane DF, McGowan DA: Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J 1993, 38:73–74.

    PubMed  CAS  Google Scholar 

  73. Imamura T, Potempa J, Tanase S, Travis J: Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 1997, 272:16062–16067.

    Article  PubMed  CAS  Google Scholar 

  74. Herzberg MC, Weyer MW: Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 1998, 3:151–160.

    PubMed  CAS  Google Scholar 

  75. Matilla RV, Nieminen M: Von Willebrand factor antigen and dental infection. Thromb Res 1989, 56:325–391.

    Article  Google Scholar 

  76. Loesche WJ, Schork A, Terpenning MS, et al.: Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans. J Am Dent Assoc 1998, 129:301–311.

    PubMed  CAS  Google Scholar 

  77. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R: Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 1998, 3:127–141.

    PubMed  CAS  Google Scholar 

  78. Seymour RA, Steele JG: Is there a link between periodontal disease and coronary heart disease? Br Dent J 1998, 184:33–38.

    Article  PubMed  CAS  Google Scholar 

  79. Joshipura KJ, Douglass CW, Willett WC: Possible explanations for the tooth loss and cardiovascular disease relationship. Ann Periodontol 1998, 3:175–183.

    PubMed  CAS  Google Scholar 

  80. Zhu J, Quyyumi AA, Norman JE, et al.: Effects of total pathogen burden on coronary artery disease risk and C- reactive protein levels. Am J Cardiol 2000, 85:140–146.

    Article  PubMed  CAS  Google Scholar 

  81. Zhu J, Nieto FJ, Horne BD, et al.: Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001, 103:45–51.

    PubMed  CAS  Google Scholar 

  82. Kiechl S, Egger G, Mayr M, et al.: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064–1070.

    PubMed  CAS  Google Scholar 

  83. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999, 100:e20–28.

    PubMed  CAS  Google Scholar 

  84. Medzhitov R, Janeway C Jr: The Toll receptor family and microbial recognition. Trends Microbiol 2000, 8:452–456.

    Article  PubMed  CAS  Google Scholar 

  85. Xu HX, Shah PK, Faure E, et al.: Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001, 104:3103–3108.

    PubMed  CAS  Google Scholar 

  86. Bachmaier K, Neu N, de la Maza LM, et al.: Chlamydia infections and heart disease linked through antigenic mimicry. Science 1999, 283:1335–1339.

    Article  PubMed  CAS  Google Scholar 

  87. Xu Q, Willeit J, Marosi M, et al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 1993, 341:255–259.

    Article  PubMed  CAS  Google Scholar 

  88. Xu Q, Luef G, Weimann S, et al.: Staining of endothelial cells and macrophages in atherosclerotic lesions with human heat-shock protein-reactive antisera. Arterioscler Thromb 1993, 13:1763–1769.

    PubMed  CAS  Google Scholar 

  89. Schett G, Xu Q, Amberger A, et al.: Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995, 96:2569–2577.

    PubMed  CAS  Google Scholar 

  90. Metzler B, Mayr M, Dietrich H, et al.: Inhibition of arteriosclerosis by T-cell depletion in normocholesterolemic rabbits immunized with heat shock protein 65. Arterioscler Thromb Vasc Biol 1999, 19:1905–1911.

    PubMed  CAS  Google Scholar 

  91. Xu Q, Kiechl S, Mayr M, et al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 1999, 100:1169–1174.

    PubMed  CAS  Google Scholar 

  92. Mayr M, Metzler B, Kiechl S, et al.: Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 1999, 99:1560–1566.

    PubMed  CAS  Google Scholar 

  93. Kol A, Bourcier T, Lichtman AH, Libby P: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571–577.

    Article  PubMed  CAS  Google Scholar 

  94. Kol A, Lichtman AH, Finberg RW, Libby P, Kurt-Jones EA: Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol 2000, 164:13–17.

    PubMed  CAS  Google Scholar 

  95. Epstein SE, Zhu J, Burnett MS, et al.: Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000, 20:1417–1420.

    PubMed  CAS  Google Scholar 

  96. Navab M, Berliner JA, Subbanagounder G, et al.: HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol 2001, 21:481–488.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology and Atherosclerosis Research Center, Cedars Sinai Medical Center, Room 5347, 8700 Beverly Boulevard, 90048, Los Angeles, CA, USA

    Prediman K. Shah MD

Authors
  1. Prediman K. Shah MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, P.K. Chronic infections and atherosclerosis/thrombosis. Curr Atheroscler Rep 4, 113–119 (2002). https://doi.org/10.1007/s11883-002-0034-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-002-0034-2

Keywords

Search

Navigation